Comments

Apogee Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Apogee Therapeutics (APGE) operate in?

Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

APGENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$39.48

-0.88-2.18%

At close: -

$39.21

-0.27-0.68%

After Hours: May 23, 7:52 PM EDT

Apogee Therapeutics (APGE) Forecast

News Earnings Apogee Therapeutics (APGE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Apogee Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APGE | Benzinga

Explore Apogee Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APGE.

Open	$39.35
Close	$39.48
Volume / Avg.	405.97K / 703.00K
Day Range	$39.14 - $40.00
52 Wk Range	26.20 - 63.50
Market Cap	$2.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	37.91%
Days to Cover	20.26

Recent News

Why Is Apogee Therapeutics Stock Trading Higher On Monday?

Apogee's APG808 cut key asthma biomarker FeNO by 53% at 12 weeks with no severe adverse events, showing potential for long-term maintenance dosing.

Vandana Singh

Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial

Apogee's APG990 Phase 1 data show a 60-day half-life and strong tolerability, supporting long-interval dosing. A 2025 trial will compare APG279 to Dupixent.

Vandana Singh

Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$39.35
Close	$39.48
Volume / Avg.	405.97K / 703.00K
Day Range	$39.14 - $40.00
52 Wk Range	26.20 - 63.50
Market Cap	$2.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	37.91%
Days to Cover	20.26

About Apogee Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Apogee Therapeutics (APGE) stock?

You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.

View our list of the best stock brokerages

Who are Apogee Therapeutics (APGE) competitors?

Other companies in Apogee Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Ascentage Pharma Group (NASDAQ:AAPG) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the forecast, or price target, for Apogee Therapeutics (APGE) stock?

Apogee Therapeutics has a consensus price target of $81.00.

What is the current price for Apogee Therapeutics (APGE)?

The stock price for Apogee Therapeutics (NASDAQ: APGE) is $39.21 last updated May 23, 2025 at 7:52 PM EDT.

Does Apogee Therapeutics (APGE) pay a dividend?

There are no upcoming dividends for Apogee Therapeutics.

When is Apogee Therapeutics (NASDAQ:APGE) reporting earnings?

Apogee Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Apogee Therapeutics (APGE) going to split?

There is no upcoming split for Apogee Therapeutics.

What sector and industry does Apogee Therapeutics (APGE) operate in?

Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.